首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1737062

全球甲狀腺疾病市場規模（按類型、治療、給藥途徑、最終用戶、地區、範圍和預測）

Global Thyroid Disorder Market Size By Type (Hypothyroidism, Hyperthyroidism), By Treatment (Medications, Radioactive Iodine Therapy), By Route of Administration (Oral, Intravenous), By End User (Hospitals, Clinics), By Geographic Scope And Forecast

出版日期: 2025年05月08日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

甲狀腺疾病市場規模及預測

2024 年甲狀腺疾病市場規模價值 24.6 億美元，預計到 2032 年將達到 33.5 億美元，預測期內（2026-2032 年）的複合年成長率為 3.17%。

甲狀腺疾病發病率上升、新型有效聯合藥物療法的推出以及需要有效聯合藥物療法的病例增加，預計將在預測期內推動市場成長。《全球甲狀腺疾病市場報告》對市場進行了全面評估，包括關鍵細分市場、趨勢、市場促進因素、限制因素、競爭格局以及影響市場的關鍵因素。

定義全球甲狀腺疾病市場

甲狀腺疾病是一種影響甲狀腺正常功能的疾病。甲狀腺是位於頸部正下方的內分泌腺，負責分泌甲狀腺激素，並幫助調節體內各種代謝活動。甲狀腺控制新陳代謝的過程，也就是人體細胞利用食物中的能量。新陳代謝會影響體溫、心率和消費量。當人體缺乏足夠的甲狀腺激素時，人體的代謝過程就會減慢。

當甲狀腺無法分泌足夠的甲狀腺激素（甲狀腺機能低下症）或分泌過多的甲狀腺激素（甲狀腺功能亢進症）時，人體的代謝和功能就會受損。體內碘缺乏是導致甲狀腺疾病的主要因素。所有甲狀腺疾病均可治療，恢復正常的甲狀腺功能。然而，這通常需要藥物來維持甲狀腺健康。大多數甲狀腺疾病患者可以透過手術或放射性碘治療治癒。

全球甲狀腺疾病市場概況

推動市場成長的關鍵因素包括甲狀腺疾病發病率的上升、疾病認知計畫的持續推進（尤其是在新興國家），以及用於治療甲狀腺疾病的有效藥物聯合治療的開發。全球各國政府機構正在提高人們對甲狀腺疾病及時診斷和治療的認知，從而推動市場的成長。此外，製藥商也積極支持認知宣傳活動，並實施推廣策略以提高公眾認知度，這有望推動市場的成長。

甲狀腺疾病市場的主要驅動力是碘缺乏患者數量的不斷成長。甲狀腺相關疾病研發和製藥領域的投資增加可能會推動市場發展。然而，諸如放射性碘 (RAI) 療法等治療方法費用高昂以及現有治療藥物的副作用等因素可能會在一定程度上抑制市場成長。

The rising number of thyroid gland disorders, the introduction of new effective combination drug therapies, and the growing number of cases requiring effective combination drug therapies are some of the factors anticipated to foster market growth during the forecast period. The Global Thyroid Disorder Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors playing a substantial role in the market.

Global Thyroid Disorder Market Definition

Thyroid disorders are medical conditions affecting the proper functioning of the thyroid gland. The thyroid gland is an endocrine gland located in the middle of lower the neck and is responsible for the production of thyroid hormones which help to regulate various metabolic activities in the body. The thyroid controls the body's cells use energy from food, a process called metabolism. Among other things, metabolism affects the body's temperature, heartbeat, and how well the body burns calories. If the body doesn't have enough thyroid hormone, human body processes slow down.

When the thyroid gland does not produce enough thyroid hormones (hypothyroidism) or too much hormone (hyperthyroidism), the metabolism and functioning of the body are disrupted. The lack of iodine in the body is a major factor that leads to thyroid disorders. All thyroid diseases can be treated, resulting in normal thyroid function. However, this frequently requires being on medication to maintain a normal thyroid state. Most patients with thyroid disorders can be cured through surgery and radioactive iodine treatments.

Global Thyroid Disorder Market Overview

The major factors that drive the growth of the market include an increase in the incidence of thyroid gland disorder, a rise in the number of disease awareness programs, especially in developing countries, and the development of effective combination drug therapies to treat thyroid gland disorder. A government organization across the globe has increased the awareness about timely diagnosis and treatment of thyroid disorders hence promoting the growth of the market. In addition, pharmaceutical manufacturers are also undertaking initiatives to support awareness campaigns or implement promotional strategies to create awareness anticipated to propel the growth of the market.

The market for thyroid disorders is primarily driven by the increasing number of patients with iodine deficiency cause of very less good sources of iodine in the diet can drive the market growth. Research and the development of medicines for thyroid-related disorders and an increase in the investments made in the pharmaceutical sector can drive the market. However, factors such as the high cost of treatment procedures such as radioactive iodine (RAI) therapy and side effects related to the available therapeutics might restrain the market growth to an extent.

Global Thyroid Disorder Market: Segmentation Analysis

The Global Thyroid Disorder Market is Segmented on the basis of Type, Treatment, Route Of Administration, End User, and Geography.

Thyroid Disorder Market, By Type

Hypothyroidism
Hyperthyroidism

Based on Type, The market is bifurcated into Hypothyroidism and Hyperthyroidism. If the body makes too much thyroid hormone, the body can develop a condition called hyperthyroidism. If the body makes too little thyroid hormone, it's called hypothyroidism. Both conditions are serious and need to be treated with effective drug therapies. Hypothyroidism is expected to gain significant traction over the forecast period. A growing population base diagnosed with the condition and the rising prevalence of iodine deficiency population across the globe is some of the factors that boost the market growth.

Thyroid Disorder Market, By Treatment

Medications
Radioactive Iodine Therapy
Surgery

Based on Treatment, The market is bifurcated into Medications, Radioactive Iodine Therapy and Surgery. Medication that boosts your levels of thyroid hormone is an easy way to treat hypothyroidism. It's not a cure, but it can keep patients' conditions under control for the long term. Also, radioactive iodine therapy is the most widely recommended permanent treatment of hyperthyroidism. This treatment takes advantage of the fact that thyroid cells are the only cells in the body that can absorb iodine.

Thyroid Disorder Market, By Route of Administration

Oral
Intravenous
Others

Based on the Route Of Administration, The market is bifurcated into Oral, Intravenous, and Others. The oral route of the administration segment is the largest contributor toward market growth. Most of the medications available in the market are in the form of tablets or pills and can be easily administered by patients.

Thyroid Disorder Market, By End User

Hospitals
Clinics
Others

Based on End Users, The market is bifurcated into Hospitals, Clinics, and Others.

Thyroid Disorder Market, By Geography

North America
Europe
Asia Pacific
Rest of the world

Based on Regional Analysis, The Global Thyroid Disorder Market is classified into North America, Europe, Asia Pacific, and Rest of the world. North America is dominating the thyroid gland disorder market. Multinational companies are frequently involved in raising awareness in American society through campaigns driving the growth of the market in the region. The Asia Pacific is expected to have significant growth during the forecast period owing to the growing population base affected with thyroid disorder is increasing demand for drugs that are further expected to boost the growth of the market.

Key Players

The "Global Thyroid Disorder Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are AbbVie Inc., Pfizer Inc., Merck & Co., Inc., Lannett Company, Inc., Allergan plc., Mylan N.V., GlaxoSmithKline plc., Novartis AG, RLC LABS, Inc., and Abbott Laboratories.

The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

1 INTRODUCTION OF GLOBAL THYROID DISORDER MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL THYROID DISORDER MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model

5 GLOBAL THYROID DISORDER MARKET, BY TYPE

5.1 Overview
5.2 Hypothyroidism
5.3 Hyperthyroidism

6 GLOBAL THYROID DISORDER MARKET, BY TREATMENT

6.1 Overview
6.2 Medications
6.3 Radioactive Iodine Therapy
6.4 Surgery

7 GLOBAL THYROID DISORDER MARKET, BY ROUTE OF ADMINISTRATION

7.1 Overview
7.2 Oral
7.3 Intravenous
7.4 Others

8 GLOBAL THYROID DISORDER MARKET, BY END USER

8.1 Overview
8.2 Hospitals
8.3 Clinics
8.4 Others

9 GLOBAL THYROID DISORDER MARKET, BY GEOGRAPHY

9.1 Overview
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 U.K.
- 9.3.3 France
- 9.3.4 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Rest of Asia Pacific
9.5 Rest of the World
- 9.5.1 Latin America
- 9.5.2 Middle East and Africa

10 GLOBAL THYROID DISORDER MARKET COMPETITIVE LANDSCAPE

10.1 Overview
10.2 Company Market Ranking
10.3 Key Development Strategies

11 COMPANY PROFILES

11.1 AbbVie Inc.
- 11.1.1 Overview
- 11.1.2 Financial Performance
- 11.1.3 Product Outlook
- 11.1.4 Key Developments
11.2 Pfizer Inc.
- 11.2.1 Overview
- 11.2.2 Financial Performance
- 11.2.3 Product Outlook
- 11.2.4 Key Developments
11.3 Merck & Co.
- 11.3.1 Overview
- 11.3.2 Financial Performance
- 11.3.3 Product Outlook
- 11.3.4 Key Developments
11.4 Lannett Company, Inc.
- 11.4.1 Overview
- 11.4.2 Financial Performance
- 11.4.3 Product Outlook
- 11.4.4 Key Developments
11.5 Allergan PLC
- 11.5.1 Overview
- 11.5.2 Financial Performance
- 11.5.3 Product Outlook
- 11.5.4 Key Developments
11.6 Mylan N.V.
- 11.6.1 Overview
- 11.6.2 Financial Performance
- 11.6.3 Product Outlook
- 11.6.4 Key Developments
11.7 GlaxoSmithKline PLC
- 11.7.1 Overview
- 11.7.2 Financial Performance
- 11.7.3 Product Outlook
- 11.7.4 Key Developments
11.8 Novartis AG
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 RLC LABS
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Abbott Laboratories
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments